Jasper Nidoi

Jasper Nidoi

Auto-generated profile, based on publicly available information

Jasper Nidoi

Department of Research and Innovation, Makerere University Lung Institute , New Mulago Hospital Complex, Upper Mulago Hill Road, Kampala P.O. Box 7749

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2024 in Health Policy and Planning
Verified
Journal Article
Open access
PDF file
JNJasper Nidoi
Jasper Nidoi
JPJustin Pulford
Justin Pulford
TWTom Wingfield
Tom Wingfield
TRThomson Rachael
Thomson Rachael
BRBeate Ringwald
Beate Ringwald
BKBruce Kirenga
Bruce Kirenga
Gender impacts exposure and vulnerability to tuberculosis (TB) evidenced by a higher prevalence of both TB disease and missed TB diagnoses among men, who significantly contribute to new TB infections. We present the formative research phase of a study, which used participatory methods to identify gender-specific interventions for systematic screening of TB among men in Uganda. Health facility-level data were collected at four Ugandan general hospitals (Kawolo, Gombe, Mityana and Nakaseke) among 70 TB stakeholders, including healthcare workers, TB survivors, policymakers and researchers. Using health-seeking pathways, they delineated and compared men’s ideal and actual step-by-step TB health-seeking processes to identify barriers to TB care. The stepping stones method, depicting barriers as a ‘river’ and each ‘steppingstone’ as a solution, was employed to identify interventions which would help link men with TB symptoms to care. These insights were then synthesized in a co-analysis meeting with 17 participants, including representatives from each health facility to develop a consensus on proposed interventions. Data across locations revealed the actual TB care pathway diverted from the ideal pathway due to health system, community, health worker and individual-level barriers such as delayed health seeking, unfavourable facility operating hours and long waiting times that conflicted with men’s work schedules. Stakeholders proposed to address these barriers through the introduction of male-specific services; integrated TB services that prioritize X-ray screening for men with cough; healthcare worker training modules on integrated male-friendly services; training and supporting TB champions to deliver health education to people seeking care; and engagement of private practitioners to screen for TB. In conclusion, our participatory co-design approach facilitated dialogue, learning and consensus between different health actors on context-specific, person-centred TB interventions for men in Uganda. The acceptability, effectiveness and cost effectiveness of the package will now be evaluated in a pilot study.

2 April 2025 in medRxiv
Verified
Preprint
Open access
ARAlexandra S Richards
Alexandra S Richards
MPMphatso D Phiri
Mphatso D Phiri
JNJasper Nidoi
Jasper Nidoi
JCJeremiah Chakaya
Jeremiah Chakaya
PMPeter MacPherson
Peter MacPherson
KHKatherine C Horton
Katherine C Horton
Background: Globally, the burden of tuberculosis (TB) falls more on men than women and children, and there are large gaps between men and women at all stages of exposure, disease incidence, and treatment. We examined the impact of addressing determinants of these gender gaps in Kenya, Malawi, Nigeria, and Uganda. Methods and Findings: We created a deterministic transmission model of TB, with strata for sex, age, and HIV co-infection and antiretroviral therapy, and calibrated to country-specific data on prevalence, incidence, mortality, and notifications between 2010 and 2022. We then examined the potential epidemiological impact of strategies to increase treatment coverage among men, and decrease the effects of social and structural determinants that increase men’s risk of developing TB. We investigated impact (overall and by age and sex) on projected incidence and mortality in 2035, and notification rates between 2025 and 2030. Relative reductions in overall TB incidence from increased treatment coverage among men ranged from 4.8% [95% uncertainty interval (UI)0.7-10.6%] in Malawi to 24.8% [UI 14.3-37.0%] in Uganda. Reducing men’s excess risk of TB led to a similar range in relative reductions from 8.4% [UI 6.6-10.4%] in Nigeria to 23.3% [UI 18.0-30.0%] in Uganda. Combining strategies increased the relative reduction beyond that seen with one strategy alone, but as would be anticipated by greater prevention of incident TB, less than the sum of both strategies. Impacts extended across the population with median estimates of country-level declines in incidence of between 1.6—10.6% and 2.8—19.5% in women and children respectively, across the four countries. Increasing treatment coverage increased the median country-level estimates of notifications between 3.1% and 12.4% in the first three years, however combining increased treatment coverage with a reduction in risk reduced the median annual country-level notifications by 6.7% to 18.1% by 2035. Conclusion: Strategies that prioritise increasing TB treatment coverage among men and mitigating men’s higher susceptibility to TB could reduce disease burden for men, women, and children. Such gender-responsive strategies are essential to ensure a person-centred TB response and accelerate global progress towards the End TB targets.

27 March 2026 in Communications Medicine
Verified
Journal Article
Open access
PDF file
ARAlexandra S. Richards
Alexandra S. Richards
MPMphatso D. Phiri
Mphatso D. Phiri
JNJasper Nidoi
Jasper Nidoi
JCJeremiah Chakaya
Jeremiah Chakaya
PMPeter MacPherson
Peter MacPherson
KHKatherine C. Horton
Katherine C. Horton
Background: Globally, the burden of tuberculosis falls more on men than women and children, and there are large gaps between men and women at all stages of exposure, disease incidence, and treatment. We examined the impact of addressing determinants of these gender gaps in Kenya, Malawi, Nigeria, and Uganda. Methods: We created a deterministic transmission model of tuberculosis, calibrated to country-specific data on prevalence, incidence, mortality, and notifications between 2010 and 2022. We examined the potential epidemiological impact of strategies to increase treatment coverage among men and decrease the effects of social and structural determinants that increase men’s risk of developing TB. We investigated the impact (overall and by age and sex) on projected incidence and mortality in 2035, and notification rates between 2025 and 2030. Results: Our modelling estimates that increasing treatment coverage among men could reduce incidence in 2035 between 2.4% [95% uncertainty interval (UI) 0.2-6.0%] in Malawi and 23.0% [UI 16.8-29.3%] in Nigeria. Reducing men’s excess risk of tuberculosis could similarly reduce incidence in 2035 between 9.8% [UI 7.5-12.6%] in Malawi and 30.1% [UI 24.1-40.5%] in Kenya. Impacts extend across the population with median estimates of country-level declines in incidence of between 0.9-17.8% and 1.4-22.2% in women and children, respectively, across the four countries. Conclusions: Strategies that prioritise increasing tuberculosis treatment coverage among men and mitigating men’s higher susceptibility to tuberculosis could reduce disease burden for men, women, and children. Such gender-responsive strategies are essential to ensure a person-centred tuberculosis response and accelerate global progress towards the EndTB targets

8 August 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CBCharles Batte
Charles Batte
ASAndrew Weil Semulimi
Andrew Weil Semulimi
JMJohn Mukisa
John Mukisa
MNMariam Nakabuye
Mariam Nakabuye
JNJasper Nidoi
Jasper Nidoi
JBJoseph B. Babigumira
Joseph B. Babigumira
Introduction: The presence of hypertension could reduce the health-related quality of life (HRQoL) of people with HIV (PWH). Yet, literature describing the HRQoL of PWH who have hypertension in Uganda is scarce making the design of locally adapted interventions cumbersome. In our study, we compared HRQoL scores of people with HIV with and without hypertension on long term antiretroviral therapy (ART) in Uganda. Methods: We recruited 149 PWH with hypertension and 159 PWH without hypertension in the long-term ART cohort at an urban clinic in Kampala, Uganda. Data on socio-demographics were collected using an interviewer designed questionnaire while data on the World Health Organisation clinical stage viral load and CD4 count as well as ART duration were extracted from clinic electronic database and a generic EuroQol -5D- 5L (EQ-5D- 5L) and Medical Outcome Study (MOS-HIV) questionnaire used to collect HRQoL data. Data were summarized using descriptive statistics while inferential statistics were used to determine associations between key variables and HRQoL. Mann-Whitney U tests were used to compare HRQoL between groups of interest. Results: One hundred ninety (61.7%) participants were female. PWH who had hypertension were older (Mean ± SD: 53.7 ± 8.3 vs 49.9 ± 8.6, p value <0.001) than those without hypertension. Participants with hypertension had lower overall median health utility scores (0.71 (0.33–0.80) vs 0.80 (0.44–0.80), p value = 0.029) and mean physical health score (48.44 ± 10.17 vs 51.44 ± 9.65, p value < 0.001) as opposed to those without hypertension. Hypertension (p value = 0.023), high income status, >70,000 UGX, (p value = 0.044), disclosure of the HIV status of the participants to their partner (p value = 0.026), and current history of smoking (p value = 0.029) were associated with low HRQoL scores. Conclusion: Among people with HIV, those with hypertension had lower HRQoL compared to those without. This calls for inclusion of quality-of-life assessment in the management of PWH who have been diagnosed with hypertension to identify those at risk and plan early interventions.